Under construction – not a live service
Sign in
Taking people in FranceNo phase

French national registry following adults with melanoma skin cancer

Collects information on people with melanoma skin cancer treated in France to support research.

Plain-language title generated from the registry record
Registry title: French Clinical Datbase of Melanoma Patients (RIC-Mel)

Key facts

Where
Nantes, FranceSee the site

Where in France

  • Nantes University HospitalNantes, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nantes University Hospital
Trial code
NCT03315468
Record updated
22 July 2025
Original description
With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of both academic and private research requires the availability information on the features of patients.Read full original descriptionShow less

French National Cohort of Patients With Melanoma (Any Stage). Network for Research and Clinical Investigation, the RIC-Mel Network.

With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of both academic and private research requires the availability information on the features of patients.

To meet this need, the French Multidisciplinary Melanoma Group (GMFMel) in collaboration with INCa (French National Cancer Institute), the CeNGEPS (National Centre for Healthcare Products Trial Management) and the CIC-BT0503 from Nantes University Hospital (Biotherapy Clinical Centre of Investigation) has set up in April 2011 a Clinical Investigation Network for melanoma, called the CeNGEPS-GMFMel network. Nowadays, the network is named :

RIC-Mel : network for Research and Clinical Investigation on Melanoma. Aims of the network are to promote translational and epidemiological projects as well as to optimize the achievements of clinical trials.

To achieve these goals, a database was launched in 2012 that gives a permanently updates mapping of melanoma treated in France with the key information needed for any research projects.

Inclusion: Patient with melanoma, of any stage,; Patient agreed to participate.

Exclusion: Individuals under court protection.

ClinicalTrials.gov NCT03315468